Former Theranos CEO Elizabeth Holmes has been approved for placement in a halfway house and is scheduled to move to the Austin Transitional Center in Del Valle, Texas, on Aug. 23, 2027, ABC News reported, citing a Justice Department notification. Her projected release date is now Feb. 22, 2030. Her sentence was reduced from 11 years and 3 months to 10 years and 3 months through a retroactive change to federal sentencing guidelines and time credits earned under the First Step Act.
The news landed the same day a federal advisory panel voted in favor of Galleri, a blood test designed to screen for many types of cancer. Nothing suggests Galleri resembles Theranos. The contrast is useful because the panel's public vote showed the kind of evidence review that Holmes' company never passed.
